| Patient | John Henry Holliday |
|---|---|
| Date of birth | 2004-08-14 |
| Identifiers | MRN HR-NI007-SYN; SSN (made up) 000-07-8153 |
| Document date | 2026-02-10 |
| Author | Martin Beaumont, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New cavitary, smear-positive pulmonary tuberculosis in a 21-year-old dentist who drinks heavily. Please confirm the regimen and doses, advise on liver monitoring given his alcohol use, and advise on isolation, return to dental work, and the length of treatment. [S]
Urgency: Urgent, within two weeks, on the same day as his two-week primary care visit. [S]
Questions for the consultant:
Two months of cough, blood-streaked sputum, night sweats, and weight loss to 58.0 kg (BMI 18.3); temperature 37.8 °C, oxygen saturation 95 percent. Chest X-ray: right upper lobe consolidation with a 3 cm cavity. First sputum smear for acid-fast bacilli 2+ today; two early-morning samples to follow, and a nucleic acid amplification test, culture, and susceptibility testing ordered. HIV, hepatitis B, and hepatitis C tests sent. Baseline ALT 34, AST 38, bilirubin 0.6, GGT 78 (high), albumin 3.4 (low), hemoglobin 12.6 (low), platelets 412 (high), HbA1c 5.2, creatinine 0.86. Visual acuity 85 letters in each eye with normal color vision. Alcohol: AUDIT 15, whiskey four or more evenings a week, often six or more drinks, mostly at late-night card games; mild alcohol use disorder; brief intervention given; safety assessment with no current risk. No other medicines; no known allergies. Plan: isoniazid 300 mg, rifampin 600 mg, pyrazinamide 1500 mg, ethambutol 1200 mg, and pyridoxine 50 mg daily by video-observed therapy with the health department, starting as soon as the amplification test confirms tuberculosis. Reported to the health department today; isolating at home [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
1 later historical claim is omitted because it describes events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance | active | confirmed | A15.0 | S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic. |
| Alcohol use disorder, mild, with binge drinking | active | confirmed | F10.10 | S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1872 | Developed a bad cough shortly after beginning to practice dentistry | D (CLM-0004) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Pulmonary tuberculosis; died of it in 1866 | D (CLM-0002) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-10 | Body height | 178 | cm | S |
| 2026-02-10 | Body weight | 58 | kg | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 18.3 | kg/m2 | S |
| 2026-02-10 | Systolic blood pressure | 112 | mm[Hg] | S |
| 2026-02-10 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-02-10 | Heart rate | 104 | /min | S |
| 2026-02-10 | Respiratory rate | 20 | /min | S |
| 2026-02-10 | Body temperature | 37.8 | Cel | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-10 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-02-10 | Leukocytes [#/volume] in Blood by Automated count | 9.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-02-10 | Platelets [#/volume] in Blood by Automated count | 412 | 10*3/uL | 150-400 10*3/uL | High | S |
| 2026-02-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 7-56 U/L | Normal | S |
| 2026-02-10 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 10-40 U/L | Normal | S |
| 2026-02-10 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-02-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 92 | U/L | 40-129 U/L | Normal | S |
| 2026-02-10 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 78 | U/L | 8-61 U/L | High | S |
| 2026-02-10 | Albumin [Mass/volume] in Serum or Plasma | 3.4 | g/dL | 3.5-5 g/dL | Low | S |
| 2026-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.86 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 124 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-02-10 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-02-10 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.2 | % | <=5.6% | Normal | S |
| 2026-02-10 | Visual acuity uncorrected Right eye by ETDRS eye chart | 85 | {letters} | >=80 | Normal | S |
| 2026-02-10 | Visual acuity uncorrected Left eye by ETDRS eye chart | 85 | {letters} | >=80 | Normal | S |
| 2026-02-10 | Total score [AUDIT] | 15 | {score} | S | ||
| 2026-02-10 | Total score [AUDIT-C] | 9 | {score} | S | ||
| 2026-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |